当前位置:
X-MOL 学术
›
Semin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Bevacizumab in breast cancer: a targeted therapy still in search of a target population.
Seminars in Oncology ( IF 3.0 ) Pub Date : 2018-03-13 , DOI: 10.1053/j.seminoncol.2017.10.011 Douglas K Marks 1 , Kevin Kalinsky 1
中文翻译:
贝伐单抗在乳腺癌中的靶向治疗仍在寻找目标人群。
更新日期:2019-11-01
Seminars in Oncology ( IF 3.0 ) Pub Date : 2018-03-13 , DOI: 10.1053/j.seminoncol.2017.10.011 Douglas K Marks 1 , Kevin Kalinsky 1
Affiliation
中文翻译:
贝伐单抗在乳腺癌中的靶向治疗仍在寻找目标人群。